These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26931474)

  • 1. Communication from Tubular Epithelial Cells to Podocytes through Sirt1 and Nicotinic Acid Metabolism.
    Hasegawa K; Wakino S; Sakamaki Y; Muraoka H; Umino H; Minakuchi H; Yoshifuji A; Naitoh M; Shinozuka K; Futatsugi K; Urai H; Kanda T; Tokuyama H; Hayashi K; Itoh H
    Curr Hypertens Rev; 2016; 12(2):95-104. PubMed ID: 26931474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes.
    Hasegawa K; Wakino S; Simic P; Sakamaki Y; Minakuchi H; Fujimura K; Hosoya K; Komatsu M; Kaneko Y; Kanda T; Kubota E; Tokuyama H; Hayashi K; Guarente L; Itoh H
    Nat Med; 2013 Nov; 19(11):1496-504. PubMed ID: 24141423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.
    Yasuda I; Hasegawa K; Sakamaki Y; Muraoka H; Kawaguchi T; Kusahana E; Ono T; Kanda T; Tokuyama H; Wakino S; Itoh H
    J Am Soc Nephrol; 2021 Jun; 32(6):1355-1370. PubMed ID: 33795425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic nephropathy: Sirt1 attenuates diabetic albuminuria.
    Bible E
    Nat Rev Nephrol; 2013 Dec; 9(12):696. PubMed ID: 24166142
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel tubular-glomerular interplay in diabetic kidney disease mediated by sirtuin 1, nicotinamide mononucleotide, and nicotinamide adenine dinucleotide Oshima Award Address 2017.
    Hasegawa K
    Clin Exp Nephrol; 2019 Aug; 23(8):987-994. PubMed ID: 30859351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirt1-Claudin-1 crosstalk regulates renal function.
    Nihalani D; Susztak K
    Nat Med; 2013 Nov; 19(11):1371-2. PubMed ID: 24202384
    [No Abstract]   [Full Text] [Related]  

  • 7. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.
    Jourdan T; Park JK; Varga ZV; Pálóczi J; Coffey NJ; Rosenberg AZ; Godlewski G; Cinar R; Mackie K; Pacher P; Kunos G
    Diabetes Obes Metab; 2018 Mar; 20(3):698-708. PubMed ID: 29106063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
    Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
    J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Sirt1 promotes exosome secretion from podocytes by inhibiting lysosomal acidification in diabetic nephropathy.
    Ding L; Li ZL; Zhou Y; Liu NC; Liu SS; Zhang XJ; Liu CC; Zhang DJ; Wang GH; Ma RX
    Mol Cell Endocrinol; 2023 Jun; 568-569():111913. PubMed ID: 36990198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular podocytes in diabetic renal disease.
    Podgórski P; Konieczny A; Lis Ł; Witkiewicz W; Hruby Z
    Adv Clin Exp Med; 2019 Dec; 28(12):1711-1715. PubMed ID: 31851794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirtuin and metabolic kidney disease.
    Wakino S; Hasegawa K; Itoh H
    Kidney Int; 2015 Oct; 88(4):691-8. PubMed ID: 26083654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD
    Li X; Li Y; Li F; Chen Q; Zhao Z; Liu X; Zhang N; Li H
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo RNA interference models of inducible and reversible Sirt1 knockdown in kidney cells.
    Chuang PY; Xu J; Dai Y; Jia F; Mallipattu SK; Yacoub R; Gu L; Premsrirut PK; He JC
    Am J Pathol; 2014 Jul; 184(7):1940-56. PubMed ID: 24952428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1: Mechanism and Protective Effect in Diabetic Nephropathy.
    Ji J; Tao P; Wang Q; Li L; Xu Y
    Endocr Metab Immune Disord Drug Targets; 2021; 21(5):835-842. PubMed ID: 33121427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Regulation Through SIRT1 in Podocytes.
    Nakatani Y; Inagi R
    Curr Hypertens Rev; 2016; 12(2):89-94. PubMed ID: 26931472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease.
    Wang Y; Zheng ZJ; Jia YJ; Yang YL; Xue YM
    J Transl Med; 2018 May; 16(1):146. PubMed ID: 29848325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
    Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
    Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming Growth Factor Beta 1 Drives a Switch in Connexin Mediated Cell-to-Cell Communication in Tubular Cells of the Diabetic Kidney.
    Hills C; Price GW; Wall MJ; Kaufmann TJ; Chi-Wai Tang S; Yiu WH; Squires PE
    Cell Physiol Biochem; 2018; 45(6):2369-2388. PubMed ID: 29587265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular endothelial cell injury and cross talk in diabetic kidney disease.
    Fu J; Lee K; Chuang PY; Liu Z; He JC
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdk5-Mediated Phosphorylation of Sirt1 Contributes to Podocyte Mitochondrial Dysfunction in Diabetic Nephropathy.
    Wang S; Yang Y; He X; Yang L; Wang J; Xia S; Liu D; Liu S; Yang L; Liu W; Duan H
    Antioxid Redox Signal; 2021 Jan; 34(3):171-190. PubMed ID: 32660255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.